Literature DB >> 24782997

Management of subclinical hypothyroidism: the thyroidologists' view.

Simon H S Pearce1, Mario Vaisman2, Jean-Louis Wemeau3.   

Abstract

Subclinical hypothyroidism is a common finding when serum thyrotropin and thyroid hormones are measured, but the benefits of treating such patients with levothyroxine remain unproven. During the 14th International Thyroid Congress, a debate and discussion relating to three different clinical case scenarios of subclinical hypothyroidism was held. The audience consisted predominantly of members of the European Thyroid Association. Participants (n = 380) voted using an electronic system to express their opinion about the treatment of the 3 cases. For a 53-year-old woman with fatigue and difficulty losing weight, who has a serum TSH of 6.8 mU/l, 49% would treat with levothyroxine. Whereas, for an 84-year-old woman with a serum TSH of 6.8 mU/l, only 8% of participants would treat with levothyroxine. In contrast, for a 39-year-old woman who is trying to become pregnant, with a serum TSH of 4.5 mU/l and strongly positive thyroid peroxidase antibodies, 95% of respondents would treat with levothyroxine. This article details the clinical case scenarios and the results of the thyroidologists' opinions on treatment. It forms a snapshot of the range of accepted clinical practice in this common condition.

Entities:  

Keywords:  Dyslipidaemia; Hashimoto's thyroiditis; Subclinical hypothyroidism; Thyrotropin

Year:  2012        PMID: 24782997      PMCID: PMC3821451          DOI: 10.1159/000335964

Source DB:  PubMed          Journal:  Eur Thyroid J        ISSN: 2235-0640


  36 in total

1.  Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy.

Authors:  Roberto Negro; Alan Schwartz; Riccardo Gismondi; Andrea Tinelli; Tiziana Mangieri; Alex Stagnaro-Green
Journal:  J Clin Endocrinol Metab       Date:  2010-06-09       Impact factor: 5.958

2.  Subclinical thyroid dysfunction as a risk factor for cardiovascular disease.

Authors:  John P Walsh; Alexandra P Bremner; Max K Bulsara; Peter O'Leary; Peter J Leedman; Peter Feddema; Valdo Michelangeli
Journal:  Arch Intern Med       Date:  2005-11-28

Review 3.  Maternal thyroid disease and preterm delivery.

Authors:  Alex Stagnaro-Green
Journal:  J Clin Endocrinol Metab       Date:  2008-11-04       Impact factor: 5.958

4.  Management practices among primary care physicians and thyroid specialists in the care of hypothyroid patients.

Authors:  M T McDermott; B R Haugen; D C Lezotte; S Seggelke; E C Ridgway
Journal:  Thyroid       Date:  2001-08       Impact factor: 6.568

5.  Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment.

Authors:  Rolf Jorde; Knut Waterloo; Hilde Storhaug; Audhild Nyrnes; Johan Sundsfjord; Trond Geir Jenssen
Journal:  J Clin Endocrinol Metab       Date:  2005-11-01       Impact factor: 5.958

6.  Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis.

Authors:  J Faber; A M Galløe
Journal:  Eur J Endocrinol       Date:  1994-04       Impact factor: 6.664

7.  Grades of hypothyroidism.

Authors:  D C Evered; B J Ormston; P A Smith; R Hall; T Bird
Journal:  Br Med J       Date:  1973-03-17

8.  Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism.

Authors:  Martin I Surks; Joseph G Hollowell
Journal:  J Clin Endocrinol Metab       Date:  2007-10-02       Impact factor: 5.958

9.  Normal flow-mediated vasodilatation of the brachial artery and carotid artery intima-media thickness in subclinical hypothyroidism.

Authors:  M D Cabral; P F S Teixeira; N A O Silva; F F C Morais; D V Soares; E Salles; J M Henriques; S P Leite; C A B Montenegro; M Vaisman
Journal:  Braz J Med Biol Res       Date:  2009-05       Impact factor: 2.590

10.  Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality.

Authors:  Nicolas Ochs; Reto Auer; Douglas C Bauer; David Nanchen; Jacobijn Gussekloo; Jacques Cornuz; Nicolas Rodondi
Journal:  Ann Intern Med       Date:  2008-05-19       Impact factor: 25.391

View more
  3 in total

1.  Is Confirmed Elevation of the Serum TSH with Normal Concentrations of Circulating Thyroid Hormones Sufficient for the Diagnosis of Subclinical Hypothyroidism?

Authors:  Pedro Weslley Souza Rosario; Gabriela Franco Mourão; Maria Regina Calsolari
Journal:  Eur Thyroid J       Date:  2015-11-20

2.  Functional TSH Receptors, Malignant Melanomas and Subclinical Hypothyroidism.

Authors:  Horea Ioan Ursu
Journal:  Eur Thyroid J       Date:  2012-08-04

3.  Long-term outcome of loss-of-function mutations in thyrotropin receptor gene.

Authors:  Yardena Tenenbaum-Rakover; Shlomo Almashanu; Ora Hess; Osnat Admoni; Ahmad Hag-Dahood Mahameed; Naama Schwartz; Stavit Allon-Shalev; Dani Bercovich; Samuell Refetoff
Journal:  Thyroid       Date:  2015-01-28       Impact factor: 6.568

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.